Search results
This New Finding About Ozempic and Wegovy Could Hurt Novo Nordisk's Stock | The Motley Fool
The Motley Fool· 2 days agoNovo Nordisk's (NVO 1.19%) GLP-1 medicines, Ozempic and Wegovy, are bestsellers and household names....
Ozempic judge’s order raises early hurdles for plaintiffs suing over side effects
Reuters· 3 days agoEvery judge presiding over consolidated mass torts cases in federal court faces the same dilemma:...
Ozempic Is In Short Supply. Here’s How That Affects Diabetics
Forbes· 7 days agoOzempic, the highly popular GLP-1 agonist drug touted by many celebrities for weight loss, is in...
As Ozempic Booms and Snack Sales Decline, Retail Requires a Refresh
WWD· 2 days agoOzempic is coming for retail. As more people try GLP-1s — according to a KFF (Kaiser Family...
Lilly launches lower-price weight loss drug without injector pen
Arizona Daily Star· 4 days ago“These new vials not only help us meet the high demand for our obesity medicine, but also broaden...
New weight-loss medication could be a medical marvel or the next health crisis
Fox News· 12 hours agoNEWYou can now listen to Fox News articles! As a physician, I have witnessed countless medical...
As September puts focus on ovarian cancer, experts stress early detection
UPI· 1 day agoAn ice sculpture of a teal ovarian cancer awareness ribbon was crafted by a Stage 3 cancer survivor....
Beauty from within: What trends will inform the next wave of innovation?
Nutraingredients.com· 5 days agoPaula Simpson, innovation, product development and branding consultant at Nutribloom Consulting,...
Doctors call for closer monitoring of patients who practice recreational drug use
UPI· 1 day ago1 of 2 | Among patients admitted to intensive cardiac care units, recent recreational drug users had...